250603-02-2

Basic information

• Product Name: Oxazole, 4-[[4-(chloromethyl)-2-methoxyphenoxy]methyl]-2-(2-furanyl)-5-methyl-
• CAS NO: 250603-02-2
• Molecular Formula: C17H16ClNO4
• Molecular Weight: 333.771
• Mol File: 250603-02-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Oxazole, 4-[[4-(chloromethyl)-2-methoxyphenoxy]methyl]-2-(2-furanyl)-5-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Oxazole, 4-[[4-(chloromethyl)-2-methoxyphenoxy]methyl]-2-(2-furanyl)-5-methyl-(250603-02-2)
• EPA Substance Registry System: Oxazole, 4-[[4-(chloromethyl)-2-methoxyphenoxy]methyl]-2-(2-furanyl)-5-methyl-(250603-02-2)

Safety Data

• Hazardous Substances Data: 250603-02-2(Hazardous Substances Data)

Upstream product

• 250603-01-1 [4-[[2-(furan-2-yl)-5-methyl-4-oxazolyl]methoxy]-3-methoxyphenyl]methanol 

Downstream Products

• 250602-49-4 E-4-[4-[2-(2-furyl)-5-methyl-4-oxazolylmethoxy]-3-mehtoxybenzyloxyimino]-4-phenylbutyric acid 
• 675144-77-1 2-(2-{3-[(4-{[2-(furan-2-yl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazol-5-yl}ethyl)pyridine 
• 675144-78-2 diethyl 2-{3-[(4-{[2-(furan-2-yl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazol-5-yl}ethylphosphonate 
• 675144-55-5 2-(furan-2-yl)-4-({2-methoxy-4-[({1-phenyl-4-[2-(1,3-thiazol-4-yl)ethyl]-1H-pyrazol-3-yl}oxy)methyl]phenoxy}methyl)-5-methyl-1,3-oxazole 
• 675144-32-8 diethyl 2-{3-[(4-{[2-(furan-2-yl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazol-4-yl}ethylphosphonate 
• 675144-03-3 ethyl 3-[(4-{[2-(furan-2-yl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazole-4-carboxylate 

Relevant articles and documents

CARBAZOLE DERIVATIVE, SOLVATE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

An object of the present invention is to provide novel carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof having an excellent adipose tissue weight reducing effect, hypoglycemic effect, and hypolipidemic effect, which are useful as a preventive and/or therapeutic agent for fatty liver, obesity, lipid metabolism abnormality, visceral adiposity, diabetes, hyperlipemia, impaired glucose tolerance, hypertension, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and the like. The above-mentioned object can be achieved by carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof, wherein the carbazole derivatives are represented by the following general formula (I): (In the formula (I), the ring A represents phenyl group or the like; X represents -O- or the like; Y represents =N- or the like; a and b represent methylene group or the like; both V and Z represent -O- or the like; W represents a C1-C10 alkylene group whose 1 or 2 hydrogen atoms may be substituted by a phenyl group or a C1-C6 alkyl group; 1,2-phenylene group; 1,3-cyclohexyl group; or the like; R1 represents methyl group or the like; R2 represents methoxy group or the like; and R3 represents carboxy group or the like.)